Brief: Microport Scientific Says Qtrly Net Profit Attributable For Shanghai Microport Endovascular Medtech (Group) RMB154.8 MLN
29/04/2026 11:28
April 29 (Reuters) - Microport Scientific Corp 0853.HK: SHANGHAI MICROPORT ENDOVASCULAR MEDTECH Q1 REVENUE RMB 370.2 MILLION QTRLY NET PROFIT ATTRIBUTABLE FOR SHANGHAI MICROPORT ENDOVASCULAR MEDTECH (GROUP) CO RMB 154.8 MILLION Further company coverage: 0853.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort Scientific
See all newsBrief: Microport Scientific Says Delay In Publication Of Interim Results
Brief: Microport Scientific Announces Delay In Publication Of 2026 Interim Results
Brief: Microport Scientific Says Shanghai Microport Endovascular Medtech Logs HY Revenue Of RMB793.95 Million
Brief: Microport Scientific Sees 12%-14% Y/Y Revenue Growth In Continuing Operations For HY
Brief: Microport Scientific Unit And Others To Sell 62% Of Shanghai Microport Orthopedics To Tinavi